GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » REMSleep Holdings Inc (OTCPK:RMSL) » Definitions » Peter Lynch Fair Value

REMSleep Holdings (REMSleep Holdings) Peter Lynch Fair Value : $-0.03 (As of May. 27, 2024)


View and export this data going back to . Start your Free Trial

What is REMSleep Holdings Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, REMSleep Holdings's PEG is 1. REMSleep Holdings's 5-Year TTM EBITDA Growth Rate is 25. REMSleep Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.00. Therefore, the Peter Lynch Fair Value for today is $-0.03.

As of today (2024-05-27), REMSleep Holdings's share price is $0.0169. REMSleep Holdings's Peter Lynch fair value is $-0.03. Therefore, REMSleep Holdings's Price to Peter Lynch Fair Value Ratio for today is N/A.


The historical rank and industry rank for REMSleep Holdings's Peter Lynch Fair Value or its related term are showing as below:



RMSL's Price-to-Peter-Lynch-Fair-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.7
* Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


REMSleep Holdings Peter Lynch Fair Value Historical Data

The historical data trend for REMSleep Holdings's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

REMSleep Holdings Peter Lynch Fair Value Chart

REMSleep Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

REMSleep Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of REMSleep Holdings's Peter Lynch Fair Value

For the Medical Devices subindustry, REMSleep Holdings's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


REMSleep Holdings's Price-to-Peter-Lynch-Fair-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, REMSleep Holdings's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where REMSleep Holdings's Price-to-Peter-Lynch-Fair-Value falls into.



REMSleep Holdings Peter Lynch Fair Value Calculation

REMSleep Holdings's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 25 *-0.001
=-0.03

REMSleep Holdings's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was $-0.00.

* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


REMSleep Holdings  (OTCPK:RMSL) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 25 instead of 15 in this case.

REMSleep Holdings's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=0.0169/-0.03
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


REMSleep Holdings Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of REMSleep Holdings's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


REMSleep Holdings (REMSleep Holdings) Business Description

Traded in Other Exchanges
N/A
Address
14175 ICOT Blvd, Suite 300, Clearwater, FL, USA, 33760
REMSleep Holdings Inc is focused on designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. The company offers the product DeltaWave which is specifically designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Geographically, the business activity of the group functions through the region of the United States.
Executives
Russell Finlay Bird 10 percent owner, officer: President 722 50TH STREET, DES MOINES IA 50312
Tom J Wood director, officer: CEO 1170 CHERRYWOOD RD, WAYCROSS GA 31503
Thomas Brookes director, officer: VP & MD OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN 5G2
Matthew Sullivan director, officer: ASST. VP OF EKOM EYA MINE DIV. 1149 TOPSAIL ROAD, MOUNT PEARL A4 AIN5G2
David M Barnes officer: Chief Financial Officer 6800 JERICHO TURNPIKE, SUITE 208E, SYOSSET NY 11791
Walter Leslie Thistle director, other: Chairman of the Board 17 COLLINGWOOD CRESCENT, MOUNT PEARL A4 A1N5C6
Kat Exploration Inc. 10 percent owner 1149 TOPSAIL ROAD, MOUNT PEARL A4 A1N5G2
Ken Stead director, 10 percent owner, officer: CEO and President 15 BLADE CRESCENT, MOUNT PEARL A4 A1N 5L1
Ronald Davis officer: PRESIDENT 4412 8TH STREET SW, VERO BEACH FL 32968

REMSleep Holdings (REMSleep Holdings) Headlines

From GuruFocus

REMSleep 510K Submission

By Marketwired Marketwired 10-28-2021

REMSleep Patent Application

By GlobeNewswire GlobeNewswire 11-20-2020

REMSleep 510K Submission

By Marketwired Marketwired 07-15-2021

RemSleep Holdings Inc. Commences Trading on OTCQB

By PurpleRose PurpleRose 07-27-2022

RemSleep Holdings Inc. Issues Letter to Shareholders

By Stock market mentor Stock market mentor 01-06-2023

REMSleep Patent Application

By Marketwired Marketwired 11-20-2020

Deltawave CPAP Interface Mask

By Marketwired Marketwired 07-06-2021

Shareholder Update

By Marketwired Marketwired 11-19-2020

REMSleep 510K

By Marketwired Marketwired 06-02-2021